Pfizer says its vaccine is 95% effective, will apply to FDA for emergency use 'within days'
The company could have 50 million doses ready before January
Pfizer Inc. said Wednesday that its coronavirus vaccine is 95% effective and does not cause any serious side effects following injection.
The data, which comes from the company's first complete set of results following its Phase 3 trial, indicates that the vaccine prevents mild and serious forms of the novel illness and is 94% effective in elderly patients, who are more susceptible to serious forms of the virus.
The company says it plans to apply to the Food and Drug Administration for emergency use authorization "within days."
If the FDA approves the two-dose vaccine, Pfizer says it may be able to produce as many as 50 million doses by the end of 2020, and up to 1.3 billion by the end of the following year.
News, not Noise
- Arizona audit flags thousands of suspect ballots, kicking issue to state's attorney general
- IRS would track all bank transactions over $600 under Biden plan; businesses revolt
- At Georgia rally, former President Trump promises 'glorious victory in 2024'
- Not in Brooklyn anymore: Rev. Al Sharpton gets shouted down at photo op along southern border
- 'Fauci' earnings mystery: No info on box office take for gushing documentary about COVID czar